Extrawell Pharmaceutical Holdings Ltd (hkse:00858) Share Price

Company Profile

Business description
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.
Contact
979 King’s Road
Suites 2206-08, 22nd Floor
Devon House, Taikoo Place
Quarry Bay
Hong Kong
HKG
T: +852 28561918
http://www.extrawell.com.hk
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
163

Recommended

These companies are our top choices for investors wanting to boost Aussie exposure.

Simonelle Mody | 15 July 2025

We raise our risk and uncertainty rating to reflect the impact of the ruling.

Esther Holloway | 13 July 2025

Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.

Sarah Hansen | 10 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,875.30	60.00	0.68%
CAC 40	7,766.21	41.96	-0.54%
DAX 40	24,060.29	100.35	-0.42%
Dow JONES (US)	44,150.95	308.70	-0.69%
FTSE 100	8,938.32	59.74	-0.66%
HKSE	24,590.12	386.80	1.60%
NASDAQ	20,766.65	126.32	0.61%
Nikkei 225	39,678.02	218.40	0.55%
NZX 50 Index	12,689.63	10.94	0.09%
S&P 500	6,264.00	4.56	-0.07%
S&P/ASX 200	8,630.30	59.90	0.70%
SSE Composite Index	3,505.00	14.65	-0.42%